Notably, the glycolic inhibitors 2-DG and 3-BP or depletion of LDHA, which catalyzed the final step of glycolysis, could partly abrogate cancer cell proliferation and tumor growth (Figure 3I–K). The gene discussed is LDHA; the disease is neoplasm.